[Holmium laser enucleation of benign prostatic hyperplasia]

Paz-Valinas L, Atienza G
Record ID 32009100405
Authors' objectives:

To assess the efficacy and safety of holmium laser enucleation of the prostate (HoLEP) versus transurethral resection in the treatment of benign prostatic hyperplasia.

Authors' recommendations: While available scientific information shows that HoLEP is at least as effective as TURP, the studies claiming this nevertheless display methodological limitations which prevent firm conclusions from being drawn.HoLEP reduces patients' obstructive symptoms and, as compared to TURP, yields similar Qmax and better PVR results. No differences were observed between the techniques in sexual function, quality of life or IPSS/AUA scale assessments.HoLEP is associated with longer intervention time, though with a lower degree of blood loss, hospital stay and urinary catheterisation time than TURP. No differences were observed between both techniques in terms of appearance of adverse effects and reintervention rates.
Project Status: Completed
Year Published: 2009
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Spain
MeSH Terms
  • Laser Therapy
  • Lasers, Solid-State
  • Prostatic Hyperplasia
Organisation Name: Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
Contact Address: Conselleria de Sanidade, Xunta de Galicia, San Lazaro s/n 15781 Santiago de Compostela, Spain. Tel: 34 981 541831; Fax: 34 981 542854;
Contact Name: avalia-t@sergas.es
Contact Email: avalia-t@sergas.es
Copyright: Galician Agency for Health Technology Assessment (AVALIA-T)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.